The Effect of Pharmacist Intervention on Blood Pressure Control
Not Applicable
- Conditions
- Hypertension
- Registration Number
- NCT01233193
- Lead Sponsor
- Universidad de Granada
- Brief Summary
The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.
- Detailed Description
Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
- Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension.
Exclusion criteria:
- Patient living with an other Hypertensive patient treated with the same medications
- Pregnant women
- Hypertensive patients with levels of systolic/diastolic blood pressure ≥ 180mmHg/110mmHg
- Patient with secondary hypertension, kidney or liver failure
- Patients already included in a care program for hypertensive patients
- Patients with a new treatment for hypertension (less than 1 month)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method blood pressure control At 6 months Percentage of patients with controlled hypertension
- Secondary Outcome Measures
Name Time Method Adherence At 6 months Percentage of adherent patients after 6 months within the trial
Trial Locations
- Locations (1)
Community Pharmacies
🇪🇸Jaén, Andalucia, Spain
Community Pharmacies🇪🇸Jaén, Andalucia, Spain